Victor Clausse
National Institutes of Health(US)National Institute of Diabetes and Digestive and Kidney Diseases(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Ubiquitin and proteasome pathways, Protein Tyrosine Phosphatases, Advanced biosensing and bioanalysis techniques, Cell death mechanisms and regulation
Most-Cited Works
- → Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer(2015)195 cited
- → Interindividual variability and co-regulation of DNA methylation differ among blood cell populations(2012)47 cited
- → Conformational constraints of cyclopentane peptide nucleic acids facilitate tunable binding to DNA(2020)31 cited
- → Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy(2016)25 cited
- → Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21(2022)19 cited
- → Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen(2022)10 cited
- → Chemical Features Important for Activity in a Class of Inhibitors Targeting the Wip1 Flap Subdomain(2018)10 cited
- → Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens(2019)9 cited
- → Variation of Tetrahydrofurans in Thyclotides Enhances Oligonucleotide Binding and Cellular Uptake of Peptide Nucleic Acids(2023)8 cited
- Sensibilisation aux drogues chimiothérapeutiques des tumeurs P53 négatives par activation de la phosphatase Wip1(2017)